Particle.news
Download on the App Store

Law Firms Court Lead Plaintiffs in Inspire Medical Securities Case Over Inspire V Rollout

Plaintiffs accuse Inspire of overstating Inspire V launch readiness.

Overview

  • A federal securities class action is pending in the District of Minnesota, styled City of Pontiac Reestablished General Employees' Retirement System v. Inspire Medical Systems, Inc., No. 0:25-cv-04247-PJS-ECW.
  • The proposed class covers investors who bought Inspire common stock from August 6, 2024 through August 4, 2025.
  • On August 4, 2025, Inspire disclosed an elongated rollout timeframe, citing incomplete center training and onboarding, delayed claims software updates effective July 1 that initially blocked billing, and customers working down surplus Inspire IV inventory.
  • Following the disclosure, the company cut 2025 EPS guidance from $2.20–$2.30 to $0.40–$0.50, and the stock fell $42.04 or roughly 32%, erasing about $1.2 billion in market value.
  • Hagens Berman, Robbins LLP, and Rosen Law Firm are soliciting investors and potential whistleblowers, with lead-plaintiff motions due January 5, 2026.